Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,659 | 937 | 97.4% |
| Education | $448.96 | 12 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,757 | 137 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,307 | 180 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,251 | 62 | $0 (2024) |
| GENZYME CORPORATION | $967.97 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $867.61 | 50 | $0 (2024) |
| Mylan Specialty L.P. | $831.94 | 47 | $0 (2024) |
| Insmed, Inc. | $621.70 | 29 | $0 (2024) |
| Grifols USA, LLC | $621.14 | 37 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $610.18 | 25 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $502.57 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,968 | 135 | GlaxoSmithKline, LLC. ($400.51) |
| 2023 | $2,697 | 131 | AstraZeneca Pharmaceuticals LP ($402.96) |
| 2022 | $3,396 | 177 | AstraZeneca Pharmaceuticals LP ($589.91) |
| 2021 | $2,164 | 136 | AstraZeneca Pharmaceuticals LP ($378.45) |
| 2020 | $421.71 | 24 | AstraZeneca Pharmaceuticals LP ($76.68) |
| 2019 | $2,021 | 124 | AstraZeneca Pharmaceuticals LP ($526.38) |
| 2018 | $1,888 | 126 | GlaxoSmithKline, LLC. ($344.08) |
| 2017 | $1,552 | 96 | GlaxoSmithKline, LLC. ($390.67) |
All Payment Transactions
949 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $6.75 | General |
| Category: HFCWO | ||||||
| 12/30/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: PULMONOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: HFCWO | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Endo-Mechanical | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Respiratory | ||||||
| 12/07/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.54 | General |
| Category: HFCWO | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: PULMONOLOGY | ||||||
| 11/19/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $119.15 | General |
| Category: Endo-Mechanical | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.81 | General |
| Category: HFCWO | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $99.48 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Pulmonology | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,529 | 2,079 | $351,111 | $168,020 |
| 2022 | 11 | 1,331 | 1,868 | $320,132 | $153,876 |
| 2021 | 10 | 1,280 | 1,713 | $294,292 | $142,447 |
| 2020 | 12 | 1,056 | 1,452 | $245,676 | $108,798 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 559 | 1,011 | $181,980 | $92,068 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 158 | 235 | $56,400 | $30,566 | 54.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $32,175 | $13,407 | 41.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $18,975 | $9,029 | 47.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 156 | 162 | $17,010 | $6,998 | 41.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 125 | 127 | $14,605 | $3,615 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 49 | $5,880 | $3,187 | 54.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 70 | 71 | $7,455 | $2,948 | 39.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 88 | 91 | $7,553 | $2,891 | 38.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 103 | 107 | $7,383 | $2,111 | 28.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 15 | 15 | $525.00 | $468.80 | 89.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $450.00 | $450.66 | 100.1% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 11 | 11 | $330.00 | $146.63 | 44.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 13 | $390.00 | $133.58 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 487 | 925 | $166,500 | $84,041 | 50.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 152 | 230 | $55,200 | $30,436 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 98 | 98 | $26,950 | $11,503 | 42.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $17,940 | $8,357 | 46.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 133 | 134 | $14,070 | $6,019 | 42.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 135 | 138 | $11,454 | $4,551 | 39.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 145 | 150 | $17,250 | $4,347 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 55 | $6,600 | $3,380 | 51.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 48 | 49 | $3,381 | $968.67 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 18 | $540.00 | $194.36 | 36.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 16 | 19 | $247.00 | $78.35 | 31.7% |
About Dr. Amy Bohan, MD
Dr. Amy Bohan, MD is a Pulmonary Disease healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477554285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Bohan, MD has received a total of $17,108 in payments from pharmaceutical and medical device companies, with $2,968 received in 2024. These payments were reported across 949 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($16,659).
As a Medicare-enrolled provider, Bohan has provided services to 5,196 Medicare beneficiaries, totaling 7,112 services with total Medicare billing of $573,141. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Gilbert, AZ
- Active Since 08/02/2005
- Last Updated 01/19/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1477554285
Products in Payments
- DUPIXENT (Biological) $2,160
- NUCALA (Biological) $813.53
- FASENRA (Biological) $753.24
- Arikayce (Drug) $621.70
- TRELEGY ELLIPTA (Drug) $604.84
- OPSUMIT (Drug) $528.09
- BREZTRI (Drug) $525.37
- Prolastin-C Liquid (Biological) $512.53
- STIOLTO RESPIMAT (Drug) $501.44
- TEZSPIRE (Biological) $498.27
- SYMBICORT (Drug) $458.60
- XYWAV (Drug) $453.72
- Yupelri (Drug) $431.40
- FASENRA (Drug) $368.61
- YUPELRI (Drug) $359.97
- Monarch Platform (Device) $357.65
- ACTHAR (Biological) $337.85
- ANORO (Drug) $336.25
- Esbriet (Biological) $278.18
- GLASSIA (Biological) $274.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Gilbert
Thomas Slobig, Md, MD
Pulmonary Disease — Payments: $19,689
Harmeet Gill, Md, MD
Pulmonary Disease — Payments: $17,836
Wahaj Ahmed, Md, MD
Pulmonary Disease — Payments: $15,107
Paul Barnard, Md, MD
Pulmonary Disease — Payments: $12,348
Dr. Ronald Servi, D.o, D.O
Pulmonary Disease — Payments: $50.10
Mrs. Lauren Ridenour, Do, DO
Pulmonary Disease — Payments: $21.94